<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Abrar A</submitter><funding>Chan Zuckerberg Foundation</funding><funding>Bill and Melinda Gates Foundation</funding><funding>Resolve to Save Lives</funding><funding>Bloomberg Philanthropies</funding><pagination>1090-1098</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11347191</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>110(17)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated.&lt;h4>Objective&lt;/h4>To compare hypertension outcomes in clinics implementing HEARTS versus clinics continuing usual hypertension care in rural Bangladesh.&lt;h4>Methods&lt;/h4>A matched-pair cluster quasi-experimental trial in Upazila Health Complexes (UHCs; primary healthcare facilities) was conducted in rural Bangladesh. A total of 3935 patients (mean age 52.3 years, 70.5% female) with uncontrolled hypertension (blood pressure (BP) ≥140/90 mm Hg regardless of treatment history) were enrolled: 1950 patients from 7 HEARTS UHCs and 1985 patients from 7 matched usual care UHCs. The primary outcome was systol</pubmed_abstract><journal>Heart (British Cardiac Society)</journal><pubmed_title>Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial.</pubmed_title><pmcid>PMC11347191</pmcid><funding_grant_id>OPP1175906</funding_grant_id><pubmed_authors>Gupta R</pubmed_authors><pubmed_authors>Al Mamun MA</pubmed_authors><pubmed_authors>Burka D</pubmed_authors><pubmed_authors>Abrar A</pubmed_authors><pubmed_authors>Hu X</pubmed_authors><pubmed_authors>Moran AE</pubmed_authors><pubmed_authors>Malik F</pubmed_authors><pubmed_authors>Sultana S</pubmed_authors><pubmed_authors>Matsushita K</pubmed_authors><pubmed_authors>Bhuiyan MR</pubmed_authors><pubmed_authors>Farrell M</pubmed_authors><pubmed_authors>Banigbe B</pubmed_authors><pubmed_authors>Appel L</pubmed_authors><pubmed_authors>Choudhury SR</pubmed_authors><pubmed_authors>Amin MR</pubmed_authors><pubmed_authors>Zhao D</pubmed_authors><pubmed_authors>Jubayer S</pubmed_authors><pubmed_authors>Akhtar J</pubmed_authors><pubmed_authors>Noor Nabi Sayem M</pubmed_authors><pubmed_authors>Alim A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial.</name><description>&lt;h4>Background&lt;/h4>The World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated.&lt;h4>Objective&lt;/h4>To compare hypertension outcomes in clinics implementing HEARTS versus clinics continuing usual hypertension care in rural Bangladesh.&lt;h4>Methods&lt;/h4>A matched-pair cluster quasi-experimental trial in Upazila Health Complexes (UHCs; primary healthcare facilities) was conducted in rural Bangladesh. A total of 3935 patients (mean age 52.3 years, 70.5% female) with uncontrolled hypertension (blood pressure (BP) ≥140/90 mm Hg regardless of treatment history) were enrolled: 1950 patients from 7 HEARTS UHCs and 1985 patients from 7 matched usual care UHCs. The primary outcome was systol</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2026-06-14T05:20:50.901Z</modification><creation>2026-06-14T03:08:47.186Z</creation></dates><accession>S-EPMC11347191</accession><cross_references><pubmed>39019496</pubmed><doi>10.1136/heartjnl-2024-324253</doi></cross_references></HashMap>